NCT06727201View on ClinicalTrials.gov

Role of Ondansetron in Spinal Anaesthesia Induced Hypotension

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

February 1, 2027

Conditions
Spinal Anaesthesia Induced Hypotension
Interventions
DRUG

Ondansetron (Zofran)

Ondansetron will be given intravenously in a dose of 0.1mg/kg 10 minutes before spinal anaesthesia as single shot.

DRUG

Saline (NaCl 0,9 %) (placebo)

normal saline infusion will be given intravenously 10 minutes before spinal anaesthesia

Trial Locations (1)

Unknown

Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT06727201 - Role of Ondansetron in Spinal Anaesthesia Induced Hypotension | Biotech Hunter | Biotech Hunter